Established in 2022, the collaboration combines CytomX’s Probody masking technology with Regeneron’s Veloci-Bi bispecific antibody platform.
The hospital introduced the technology as part of its broader strategy to expand minimally invasive surgical options and align with global standards in clinical care.
The plan follows Arada’s acquisition of a controlling stake in Reem Hospital, marking the company’s entry into the healthcare sector as it expands its presence across non-residential industries.
The new campus brings a modern approach to training healthcare professionals by embedding artificial intelligence, data analytics, and digital health tools directly into clinical learning.
Through this arrangement, Pfizer aims to accelerate the identification and design of new therapeutic candidates, particularly in areas where traditional research methods have faced limitations.
The initiative will also involve coordination with World Health Organization, Africa Centres for Disease Control and Prevention, and UNICEF to ensure alignment with national outbreak response plans and immunization priorities.
Alzheimer’s disease is characterized by the accumulation of tau protein in the brain, which gradually damages nerve cells and impairs memory and cognitive function.
The equipment was officially received by Ministry of Health Permanent Secretary for Donor Coordination, Dr. George Sinyangwe, during a handover ceremony attended by senior government officials and public health leaders.
This new allocation builds on earlier support, which includes US$350 million in Ebola response and broader humanitarian assistance across the DRC, South Sudan, and Uganda.
This marks the sixth visit of Mercy Ships to Madagascar since 1996, reflecting a long-term partnership aimed at strengthening surgical systems and expanding access to life-changing care.